Ask Our Doctors and Nurses!

CYCLOPHOSPHAMIDE Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

CYCLOPHOSPHAMIDE Safety Reports

Total CYCLOPHOSPHAMIDE reports: 525.
CYCLOPHOSPHAMIDE FDA safety alerts: No.
Reported deaths: 83    Reported hospitalizations: 320.
Take CYCLOPHOSPHAMIDE Side Effects Survey or Share Your CYCLOPHOSPHAMIDE Story. Read More Here.

Showing 1-75 of 525 Next >

Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Feb 26, 2007. Female patient, 49 years of age, was diagnosed with chronic lymphocytic leukaemia stage 1 and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: autoimmune neutropenia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FLUDARABINE, RITUXIMAB. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Female patient, weighting 190.3 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: convulsion, dizziness, dyspnoea, echocardiogram abnormal, hypotension, hypoxia, loss of consciousness, pulmonary function test abnormal, respiratory alkalosis. CYCLOPHOSPHAMIDE dosage: 4000 MG. During the same period patient was treated with MELPHALAN, VALSARTAN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported CYCLOPHOSPHAMIDE problem on Feb 15, 2007. Female patient, 67 years of age, was diagnosed with dermatomyositis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, cell marker increased, condition aggravated, dermatomyositis, infection in an immunocompromised host, interstitial lung disease, pneumonia cytomegaloviral. CYCLOPHOSPHAMIDE dosage: 50 MG; QD. During the same period patient was treated with PREDNISOLONE, ORAPRED. Patient died.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from NORWAY on Mar 05, 2007. Female patient, 30 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, VINCRISTINE, RITUXIMAB, PREDNISOLONE. Patient recovered.

Health Professional from NORWAY reported CYCLOPHOSPHAMIDE problem on Mar 05, 2007. Female patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with ETOPOSIDE, DOXORUBICIN, VINCRISTINE SULPHATE, PREDNISOLONE, RITUXIMAB. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from NORWAY on Mar 05, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, VINCRISTINE SULPHATE, RITUXAN, PREDNISOLONE. Patient recovered.

Health Professional from UNITED KINGDOM reported CYCLOPHOSPHAMIDE problem on Mar 05, 2007. Female patient, 47 years of age, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PACLITAXEL, EPIRUBICIN. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2007. Male patient, weighting 185.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: chest pain, hypotension, hypoxia, neutropenic sepsis. CYCLOPHOSPHAMIDE dosage: 940 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Health Professional from NORWAY reported CYCLOPHOSPHAMIDE problem on Mar 05, 2007. Female patient, 49 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, VINCRISTINE SULPHATE, RITUXIMAB, PREDNISOLONE. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Physician from UNITED STATES on Feb 26, 2007. Female patient, 49 years of age, weighting 162.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: arthralgia, benign familial haematuria, biopsy kidney abnormal, condition aggravated, protein urine present, rash, red blood cell abnormality. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PREDNISOLONE, PLAQUENIL, LISINOPRIL, NIFEDIPINE. Patient died.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Mar 08, 2007. Male patient, weighting 145.5 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: metabolic acidosis, renal failure, respiratory rate increased, tumour lysis syndrome. CYCLOPHOSPHAMIDE dosage: 2608 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, DEPOCYT, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2007. Female patient, weighting 224.9 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, pancreatitis, white blood cell count decreased. CYCLOPHOSPHAMIDE dosage: 1218 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, COMPAZINE, ENALAPRIL MALEATE. Patient recovered.

Health Professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Mar 06, 2007. Male patient, 34 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: disease progression, oesophageal perforation, sepsis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE SULPHATE, PREDNISONE. Patient died.

CYCLOPHOSPHAMIDE problem was reported by a Physician from UNITED STATES on Mar 06, 2007. Male patient, 49 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: haemoptysis, mediastinal abscess, pulmonary vascular disorder. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE. Patient died.

Health Professional from NORWAY reported CYCLOPHOSPHAMIDE problem on Mar 05, 2007. Female patient, 58 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, VINCRISTINE SULPHATE, RITUXIMAB, PREDNISOLONE. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from on Mar 05, 2007. Female patient, 47 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: alopecia, atrioventricular block, atrioventricular block complete, atrioventricular block second degree, bradycardia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with EPIRUBICIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Mar 07, 2007. Female patient, 30 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from on Mar 07, 2007. Female patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB. Patient recovered.

Health Professional from INDIA reported CYCLOPHOSPHAMIDE problem on Mar 09, 2007. Female patient, 18 years of age, was diagnosed with ovarian neoplasm, pleurodesis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: chylothorax. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, CARBOPLATIN, BLEOMYCIN SULPHATE. Patient was hospitalized. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on Mar 06, 2007. Male patient, 34 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: disease progression, oesophageal perforation, sepsis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE SULPHATE, PREDNISONE. Patient died.

Physician from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Mar 06, 2007. Male patient, 49 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: haemoptysis, mediastinal abscess, pulmonary vascular disorder. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE. Patient died.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on Mar 06, 2007. Male patient, 34 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: disease progression, oesophageal perforation, sepsis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE SULPHATE, PREDNISONE. Patient died.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Mar 07, 2007. Male patient, 22 years of age, was diagnosed with prophylaxis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cerebral toxoplasmosis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with BUSULFAN, CYCLOSPORINE, MABCAMPATH, SULFAMETHOXAZOLE, TRIMETHOPRIM. Patient died.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on Mar 07, 2007. Female patient, 66 years of age, was diagnosed with breast cancer, antiemetic supportive care and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cystitis, discomfort, pollakiuria. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, BRICANYL, CYCLIZINE, DEXAMETHASONE, DOMPERIDONE, LUMIGAN, METOCLOPRAMIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Mar 14, 2007. Female patient, weighting 181.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, pancytopenia, pericardial effusion, pericarditis, pulmonary hypertension, pulmonary oedema, radiation pneumonitis. CYCLOPHOSPHAMIDE dosage: 17040 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, IFOSFAMIDE, VINBLASTINE SULPHATE, VINCRISTINE SULPHATE, CELEBREX, BOSENTAN, ENALAPRIL MALEATE. Patient was hospitalized. Patient died on 03/09/2007.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2007. Female patient, weighting 149.9 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. CYCLOPHOSPHAMIDE dosage: 3000 MG. During the same period patient was treated with DOCETAXEL, DOXORUBICIN HYDROCHLORIDE, ALTACE, HYDROCHLOROTHIAZIDE, LONG ACTING INSULIN, VYTORIN. Patient died on 03/02/2007.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Mar 15, 2007. Female patient, weighting 93.70 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: colitis, gastrointestinal necrosis, mesenteric vein thrombosis, multi-organ failure, neutropenia, septic shock, urinary retention. CYCLOPHOSPHAMIDE dosage: 675 MG. During the same period patient was treated with TAXOTERE, DOXORUBICIN HYDROCHLORIDE, NEUPOGEN. Patient was hospitalized. Patient died on 03/02/2007.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from ITALY on Mar 20, 2007. Female patient, 41 years of age, weighting 169.8 lb, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, oesophagitis, performance status decreased, stomatitis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, CAPECITABINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Mar 20, 2007. Female patient, weighting 224.9 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, white blood cell count decreased. CYCLOPHOSPHAMIDE dosage: 1218 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on Mar 21, 2007. Female patient, 37 years of age, weighting 165.3 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, headache, mental status changes, pancytopenia. CYCLOPHOSPHAMIDE dosage: 650 MG/M2 DAY 1, 15, 29 IV. During the same period patient was treated with CYTARABINE, MERCAPTOPURINE, METHOTREXATE, ACYCLOVIR, CEFTAZIDIME, FLUCONAZOLE, FLUOXETINE, LORAZEPAM. Patient died on 03/10/2007.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Mar 22, 2007. Female patient, weighting 118.2 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: diverticulitis, febrile neutropenia. CYCLOPHOSPHAMIDE dosage: 966 MG. During the same period patient was treated with DOXIL, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, DARVON, DESICCATED THYROID, MERREM, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2007. Female patient, weighting 190.3 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: atrial septal defect, cardiac aneurysm, convulsion, dyspnoea, hypotension, hypoxia, respiratory alkalosis, respiratory arrest, splenic infarction. CYCLOPHOSPHAMIDE dosage: 4000 MG. During the same period patient was treated with MELPHALAN, NEUPOGEN, VALSARTAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Mar 21, 2007. Male patient, 19 years of age, weighting 198.4 lb, was diagnosed with lupus nephritis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cholecystitis acute. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FOLIC ACID, RANITIDINE, ENALAPRIL MALEATE, LOSARTAN POSTASSIUM, ASPIRIN. Patient was hospitalized. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2007. Male patient, weighting 185.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: arrhythmia, chest pain, febrile neutropenia, heart rate increased, hypotension, hypoxia, neutropenic sepsis, white blood cell count decreased. CYCLOPHOSPHAMIDE dosage: 940 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported CYCLOPHOSPHAMIDE problem on Mar 30, 2007. Female patient, 47 years of age, was diagnosed with breast cancer, maintenance of anaesthesia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: alopecia, atrioventricular block second degree. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TAXOL, EPIRUBICIN, DESFLURANE, REMIFENTANIL. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 30, 2007. Female patient, 47 years of age, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TAXOL, EPIRUBICIN. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported CYCLOPHOSPHAMIDE problem on Mar 30, 2007. Female patient, 47 years of age, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PACLITAXEL, EPIRUBICIN. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from ITALY on Mar 20, 2007. Male patient, child 9 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: gene mutation identification test positive, infection, pancytopenia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with VINCRISTINE, ELSPAR, STEROIDS. Patient recovered.

Health Professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Mar 28, 2007. Male patient, 52 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, graft versus host disease, thrombocytopenia. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, HEMATOPOETIC PROGENITOR CELLS, BUSULFAN, TACROLIMUS. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on Mar 28, 2007. Male patient, 31 years of age, was diagnosed with non-hodgkin's lymphoma, malignant neoplasm progression, prophylaxis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: engraftment syndrome, malignant neoplasm progression, staphylococcal sepsis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE, CARMUSTINE, METHOTREXATE, PREDNISONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Apr 03, 2007. Female patient, weighting 115.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, respiratory arrest. CYCLOPHOSPHAMIDE dosage: 1147 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 02, 2007. Female patient, weighting 133.8 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, atrial flutter, cytomegalovirus viraemia, neutropenia, pleural effusion, renal failure, respiratory failure, sepsis. CYCLOPHOSPHAMIDE dosage: 11980 MG. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported CYCLOPHOSPHAMIDE problem on Mar 27, 2007. Male patient, 43 years of age, was diagnosed with burkitt's lymphoma, acquired immunodeficiency syndrome and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: back pain, blood cholesterol increased, blood triglycerides increased, osteonecrosis, osteoporosis, pain in extremity, spinal compression fracture, spinal fracture. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, DOXORUBICIN, HYDROCORTISONE, VINCRISTINE, PREDNISOLONE, CYTOSINE ARABINOSIDE, RITONAVIR, SAQUINAVIR. Patient was hospitalized. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from ITALY on Apr 04, 2007. Male patient, 21 years of age, was diagnosed with rhabdomyosarcoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, fibrosis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE. Patient recovered.

Health Professional from UNITED KINGDOM reported CYCLOPHOSPHAMIDE problem on Apr 04, 2007. Female patient, 47 years of age, was diagnosed with breast cancer, maintenance of anaesthesia and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: alopecia, atrioventricular block second degree. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TAXOL, EPIRUBICIN, DESFLURANE, REMIFENTANIL. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED KINGDOM on Apr 04, 2007. Female patient, 47 years of age, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PACLITAXEL, EPIRUBICIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported CYCLOPHOSPHAMIDE problem on Apr 04, 2007. Female patient, 47 years of age, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PACLITAXEL, EPIRUBICIN. Patient was hospitalized. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 04, 2007. Female patient, 47 years of age, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PACLITAXEL, EPIRUBICIN. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported CYCLOPHOSPHAMIDE problem on Apr 04, 2007. Female patient, 47 years of age, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TAXOL, EPIRUBICIN. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED KINGDOM on Apr 05, 2007. Female patient, 45 years of age, weighting 167.6 lb, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: anaemia, cough, febrile neutropenia, neutropenic sepsis, pharyngolaryngeal pain. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PACLITAXEL, EPIRUBICIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Apr 05, 2007. Male patient, weighting 163.1 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, headache, injection site pain, leukopenia, pyrexia. CYCLOPHOSPHAMIDE dosage: 2000 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Female patient, 73 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, deep vein thrombosis, diffuse alveolar damage, enterococcal infection, interstitial lung disease, lung infection pseudomonal, multi-organ failure, pneumomediastinum, pneumothorax. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with AMIODARONE, RITUXIMAB. Patient was hospitalized. Patient died.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Apr 09, 2007. Male patient, weighting 185.0 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, pneumonia, white blood cell count decreased. CYCLOPHOSPHAMIDE dosage: 940 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Male patient, weighting 157.0 lb, was diagnosed with prostate cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: neutropenia, thrombocytopenia. CYCLOPHOSPHAMIDE dosage: 100 MG QD X14DAY Q 28 DAY PO. During the same period patient was treated with ETOPOSIDE, AMBIEN, PHENERGAN, ASPIRIN, OXYCODONE, OXYCONTIN, AVANDIA, GLIMEPIRIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Apr 10, 2007. Female patient, weighting 154.3 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, white blood cell count decreased. CYCLOPHOSPHAMIDE dosage: 1300 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, weighting 231.5 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: body temperature increased, cellulitis, haemoglobin decreased, refusal of treatment by patient, white blood cell count decreased. CYCLOPHOSPHAMIDE dosage: 1218 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Apr 16, 2007. Female patient, weighting 109.1 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, neutropenia. CYCLOPHOSPHAMIDE dosage: 1100 MG. During the same period patient was treated with PEGFILGRASTIM. Patient was hospitalized. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 19, 2007. Male patient, weighting 282.2 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, mental status changes, urinary tract infection. CYCLOPHOSPHAMIDE dosage: 1793 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, AMLODIPINE, ASPIRIN, COREG, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Apr 20, 2007. Female patient, 74 years of age, weighting 163.1 lb, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: venous thrombosis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with EPIRUBICIN, FLUOROURACIL. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from ITALY on Apr 13, 2007. Female patient, 56 years of age, was diagnosed with metastases to bone and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: bone debridement, bone disorder, ear pain, haemorrhage, local anaesthesia, osteitis, osteonecrosis, paraesthesia oral. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with EPIRUBICIN, DOCETAXEL, VINORELBINE, FLUOROURACIL, PAMIDRONATE DI, ZOLEDRONATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Apr 20, 2007. Female patient, weighting 147.3 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, pain, rash maculo-papular, rash morbilliform, rash pruritic, skin lesion, varicella. CYCLOPHOSPHAMIDE dosage: 4000 MG. During the same period patient was treated with TAXOTERE, DOXORUBICIN HYDROCHLORIDE, ZOFRAN, ATARAX, ATIVAN, CLARITIN. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2007. Male patient, weighting 160.7 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: systemic mycosis. CYCLOPHOSPHAMIDE dosage: 2244 MG. During the same period patient was treated with DAUNORUBICIN, DEXAMETHASONE, ELSPAR, VINCRISTINE SULPHATE. Patient was hospitalized. Patient died on 04/06/2007.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Apr 20, 2007. Female patient, weighting 124.3 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: fatigue, neutropenia. CYCLOPHOSPHAMIDE dosage: 966 MG. During the same period patient was treated with DOXIL, NEULASTA, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, AVELOX, DARVON, FLAGYL. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2007. Female patient, weighting 112.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: decreased appetite, diarrhoea, dizziness, painful defaecation. CYCLOPHOSPHAMIDE dosage: 900 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ITALY reported CYCLOPHOSPHAMIDE problem on Apr 13, 2007. Female patient, 56 years of age, was diagnosed with metastases to bone and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: bone debridement, bone disorder, ear pain, haemorrhage, local anaesthesia, osteitis, osteonecrosis, paraesthesia oral. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with EPIRUBICIN, DOCETAXEL, VINORELBINE, FLUOROURACIL, PAMIDRONATE DI, ZOLEDRONATE. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Male patient, weighting 146.4 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, hypotension, pneumonia, sepsis, white blood cell count decreased. CYCLOPHOSPHAMIDE dosage: 940 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Apr 23, 2007. Female patient, weighting 187.6 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. CYCLOPHOSPHAMIDE dosage: 1200 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, LEVAQUIN, NEXIUM, TYLENOL. Patient was hospitalized. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 27, 2007. Female patient, 31 years of age, weighting 127.9 lb, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: appendicitis. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, LAFOL, DEXAMETHASONE PHOSPHATE, APREPITANT, GRANISETRON, VITAMIN B6, PASPERTIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Apr 26, 2007. Female patient, weighting 159.6 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: catheter related complication, catheter thrombosis, deep vein thrombosis. CYCLOPHOSPHAMIDE dosage: 3268 MG. During the same period patient was treated with CYTARABINE, MERCAPTOPURINE, METHOTREXATE. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2007. Female patient, weighting 193.6 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Apr 30, 2007. Female patient, weighting 109.1 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, clostridium difficile colitis, dehydration, neutropenia, vomiting. CYCLOPHOSPHAMIDE dosage: 1100 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULPHATE, PEGFILGRASTIM. Patient was hospitalized. Patient recovered.

CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2007. Female patient, weighting 174.2 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: feeling hot, hyperhidrosis, loss of consciousness, myocardial infarction, nausea. CYCLOPHOSPHAMIDE dosage: 1100 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, ASPIRIN, LIPITOR, NORVASC. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Apr 25, 2007. Female patient, 73 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cardiopulmonary failure, deep vein thrombosis, hypoxia, interstitial lung disease, lung infection pseudomonal, multi-organ failure, pneumomediastinum, pneumothorax, pulmonary toxicity. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PREDNISONE, RITUXIMAB, DOXORUBICIN, VINCRISTINE, AMIODARONE, SIMVASTATIN, WARFARIN, ATENOLOL. Patient was hospitalized. Patient died.

CYCLOPHOSPHAMIDE problem was reported by a Health Professional from SWITZERLAND on May 07, 2007. Female patient, 62 years of age, was diagnosed with non-hodgkin's lymphoma, prophylaxis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, malignant neoplasm progression, reversible posterior leukoencephalopathy syndrome. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, RITUXIMAB, PREDNISONE, FILGRASTIM. Patient was hospitalized. Patient died.

Health Professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on May 01, 2007. Male patient, 65 years of age, weighting 207.2 lb, was diagnosed with breast cancer, nausea and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, caecitis, condition aggravated, diarrhoea, dizziness, dizziness postural, full blood count decreased, hypotension, loss of consciousness. CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TAXOTERE, ADRIAMYCIN PFS, EMEND, COMPAZINE, KYTRIL, LIPITOR, SINGULAIR, CARDIZEM. Patient was hospitalized. Patient died on 02/16/2007.

Showing 1-75 of 525 Next >